Shufro Rose & Co. LLC Lowers Holdings in Nutrien Ltd (NYSE:NTR)

Share on StockTwits

Shufro Rose & Co. LLC cut its stake in Nutrien Ltd (NYSE:NTR) by 3.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 219,169 shares of the company’s stock after selling 6,891 shares during the period. Nutrien makes up about 1.2% of Shufro Rose & Co. LLC’s portfolio, making the stock its 26th biggest holding. Shufro Rose & Co. LLC’s holdings in Nutrien were worth $12,646,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also bought and sold shares of the company. Boston Partners grew its position in Nutrien by 6.1% during the 2nd quarter. Boston Partners now owns 8,687,741 shares of the company’s stock worth $472,439,000 after acquiring an additional 496,801 shares during the last quarter. TD Asset Management Inc. grew its position in Nutrien by 4.1% during the 2nd quarter. TD Asset Management Inc. now owns 8,335,145 shares of the company’s stock worth $453,179,000 after acquiring an additional 331,876 shares during the last quarter. CIBC Asset Management Inc grew its position in Nutrien by 2.0% during the 2nd quarter. CIBC Asset Management Inc now owns 6,991,400 shares of the company’s stock worth $380,417,000 after acquiring an additional 140,099 shares during the last quarter. Great West Life Assurance Co. Can grew its position in Nutrien by 1.9% during the 2nd quarter. Great West Life Assurance Co. Can now owns 5,110,815 shares of the company’s stock worth $278,927,000 after acquiring an additional 95,380 shares during the last quarter. Finally, Toronto Dominion Bank grew its position in Nutrien by 177.3% during the 2nd quarter. Toronto Dominion Bank now owns 3,677,431 shares of the company’s stock worth $200,088,000 after acquiring an additional 2,351,420 shares during the last quarter. 66.36% of the stock is owned by institutional investors.

NTR stock opened at $53.75 on Friday. The company has a market cap of $32.90 billion, a P/E ratio of 43.00, a PEG ratio of 1.92 and a beta of 0.76. Nutrien Ltd has a fifty-two week low of $40.41 and a fifty-two week high of $58.99.

Nutrien (NYSE:NTR) last issued its quarterly earnings data on Monday, November 5th. The company reported $0.47 EPS for the quarter, topping the consensus estimate of $0.44 by $0.03. The firm had revenue of $4.03 billion during the quarter, compared to the consensus estimate of $3.83 billion. Nutrien had a return on equity of 12.95% and a net margin of 1.74%. The firm’s revenue for the quarter was up 226.9% on a year-over-year basis. Analysts anticipate that Nutrien Ltd will post 2.67 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 17th. Stockholders of record on Monday, December 31st will be paid a $0.43 dividend. The ex-dividend date is Friday, December 28th. This is an increase from Nutrien’s previous quarterly dividend of $0.40. This represents a $1.72 annualized dividend and a dividend yield of 3.20%.

A number of equities research analysts recently weighed in on NTR shares. Royal Bank of Canada set a $65.00 price objective on Nutrien and gave the stock a “buy” rating in a research report on Tuesday, October 2nd. Macquarie upped their price target on Nutrien from $59.00 to $66.00 and gave the company an “outperform” rating in a research report on Friday, October 12th. Barclays started coverage on Nutrien in a research report on Tuesday, September 4th. They issued an “overweight” rating and a $65.00 price target on the stock. Zacks Investment Research upgraded Nutrien from a “hold” rating to a “buy” rating and set a $61.00 price target on the stock in a research report on Saturday, September 8th. Finally, Stephens set a $64.00 target price on Nutrien and gave the company a “buy” rating in a research report on Monday, August 6th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. Nutrien presently has an average rating of “Buy” and an average target price of $62.67.

WARNING: This piece of content was first reported by BBNS and is the sole property of of BBNS. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of international trademark and copyright laws. The legal version of this piece of content can be accessed at https://baseballnewssource.com/2018/11/18/shufro-rose-co-llc-sells-6891-shares-of-nutrien-ltd-ntr/2887040.html.

Nutrien Profile

Nutrien Ltd. produces and markets crop nutrients worldwide. The company offers potash, nitrogen, phosphate, and solid and liquid phosphate fertilizers; and phosphate feed, ammonium sulfate, and industrial acid products. It also retails seeds, crop protection and crop nutrient products, merchandise products, and agronomic services through operating 1,500 retail locations.

Featured Article: Fundamental Analysis and Individual Investors

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.